Human Medicine:

The Christie Pathology Partnership

The Christie Pathology Partnership (CPP) is a joint venture between SYNLAB and The Christie NHS Foundation Trust in Manchester. Commencing in 2014, the Partnership will run for 10 years and operates out of the existing Christie pathology laboratories, where around 70 staff have transferred from the NHS to the CPP.

The Christie Pathology Partnership delivers a high quality, responsive pathology diagnostic service to The Christie and other healthcare providers regionally and nationally.

The Christie is the largest single site cancer centre in Europe, treating more than 44,000 patients a year, and the first UK centre to be officially accredited as a comprehensive cancer centre. The Christie is an international leader in research, with world first breakthroughs for over 100 years, its clinical trials unit is the largest early phase trials unit in the world, with around 200 trials ongoing at any one time. The Christie School of Oncology also provides undergraduate education, clinical professional and medical education and is the first of its kind in the UK.

SYNLAB is delighted to work with The Christie and to be able to bring its expertise in running highly efficient laboratory diagnostics to the fore. The Christie Pathology Partnership is well placed to benefit from the scale of SYNLAB operations, including access to specialist testing facilities and best practices across the SYNLAB laboratory network.

Contact Us

The Christie Pathology Partnership operate within Christie. If you would like to find out more, you can:

  • use the contact form
  • Address
    The Christie Pathology Partnership
    The Christie NHS Foundation Trust
    Wilmslow Road
    Manchester
    M20 4BX
Testing

The range of services provided includes Blood Sciences (incorporating Biochemistry, Haematology, Blood Transfusion, Stem Cell Processing), Histopathology, Oncology Cytogenetics, Breast Tumour Receptor testing and Bereavement and Mortuary services. The CPP is able to call upon the unrivalled expertise and knowledge of The Christie’s extensive team of consultants, many of whom are world-class specialists in their field.

Quality

All of the services at The Christie Pathology Partnership; Biochemistry, Cytogenetics, Haematology, Transfusion and Histopathology, hold full UKAS accreditation. Histopathology and Stem cell processing are also licenced by the HTA and the Stem Cell processing laboratory is accredited with JACIE as part of the transplant programme.

Management Team

General Manager Susan Clark

Sue has more than 26 years of experience of working in Pathology, including 13 years at management level. Sue has held the position of General Manager at The Christie Pathology Partnership since January 2016.

Latest Human Medicine News
SYNLAB announce partnership with Docly

14 May 2020 New partnership sees comprehensive health tests offered to customers remotely across key UK & Ireland industry sectors UK & Ireland employers and…

Read More (about 'SYNLAB announce partnership with Docly')
SYNLAB Laboratory Services Maintains ISO 15189:2012 UKAS Accreditation

7th April 2020 – SYNLAB Laboratory Services, part of Europe’s leading medical diagnostics provider SYNLAB Group, is pleased to announce that the company has successfully…

Read More (about 'SYNLAB Laboratory Services Maintains ISO 15189:2012 UKAS Accreditation')
Press statement: SYNLAB UK & Ireland confirmed as preferred NHS strategic partner

21 January 2020 SYNLAB UK & Ireland has been confirmed as the preferred strategic partner to transform and deliver NHS pathology services in South East London. SYNLAB…

Read More (about 'Press statement: SYNLAB UK & Ireland confirmed as preferred NHS strategic partner')
Pathology First shortlisted as a finalist for the HSJ Partnership Awards 2020

16 December 2019 SYNLAB UK & Ireland is delighted to announce Pathology First has been shortlisted as a finalist in the category of Best Healthcare…

Read More (about 'Pathology First shortlisted as a finalist for the HSJ Partnership Awards 2020')